Mechanism of bromocriptine-induced hyperglycaemia

Area of Science:

• Endocrinology
• Pharmacology

Background:

• Bromocriptine is a dopamine receptor agonist with various physiological effects.
• Understanding its impact on glucose metabolism is crucial for clinical applications.

Purpose of the Study:

• To investigate the effects of bromocriptine on glucose homeostasis in rodent models.
• To elucidate the hormonal mechanisms underlying bromocriptine-induced hyperglycemia.

Main Methods:

• Administration of bromocriptine to mice and rats at specific dosages.
• Measurement of serum glucose, liver glycogen, insulin, corticosterone, triiodothyronine (T3), and thyroxine (T4) levels.
• Assessment of bromocriptine's effects following adrenalectomy in mice.

Main Results:

• Bromocriptine (6 mg/kg, IP) induced hyperglycemia and increased liver glycogen in mice.
• Adrenalectomy reduced bromocriptine's hyperglycemic effect and abolished its impact on liver glycogen in mice.
• Bromocriptine (17.5 mg/kg, IP) in rats caused hyperglycemia, reduced insulin, and increased corticosterone, without affecting T3 or T4 levels.

Conclusions:

• Bromocriptine-induced hyperglycemia in rats is partly mediated by insulin inhibition and corticosterone stimulation.
• The adrenal glands play a role in mediating bromocriptine's effects on glucose metabolism.